adenosine deaminase gene therapy (Cardium)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameadenosine deaminase gene therapy (Cardium)

Drug Alias Nameadenosine deaminase gene-transfected hematopoietic stem cells (Cardium)adenosine deaminase gene-transfected hematopoietic stem cells (Cardium)

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy

Mechanisms of ActionAdenosine deaminase stimulants

TargetsAdenosine deaminase

Therapy Area/IndicationsImmunologic Deficiency Syndromes

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Clinical)

Highest Status in ChinaN/A

Originator CompaniesGene Biotherapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGene Biotherapeutics Inc

Active IndicationsN/A

Inactive IndicationsImmunologic Deficiency Syndromes

Other Information

ATC CodeN/A